Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
39 studies found for:    " October 05, 2011":" November 04, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed
Has Results
A Study to Assess the Safety, Tolerability and Efficacy of TMC435 Along With Pegylated Interferon Alpha-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Patients Co-infected With Human Immunodeficiency Virus-Type 1
Condition: Hepatitis C Virus Genotype-1
Interventions: Drug: TMC435;   Drug: Pegylated interferon alpha-2a;   Drug: Ribavirin
22 Unknown  Video-Based Delivery of HIV Test Information for Spanish-Speaking Latinos
Conditions: HIV;   AIDS
Intervention: Behavioral: Video or In-Person Presentation
23 Completed Comparison of Door-to-door Versus Community Gathering to Provide HIV Counseling and Testing Services in Rural Lesotho
Conditions: HIV/AIDS;   Tuberculosis;   Diabetes Mellitus;   Arterial Hypertension
Interventions: Other: Door-to-door;   Other: Pitso
24 Unknown  Bioequivalence Study of Pediatric Formulations to Treat HIV Infection
Conditions: HIV;   AIDS
Interventions: Drug: Epivir®, Retrovir® and Viramune®;   Drug: Lamivudine, Zidovudine and nevirapine;   Drug: Lamivudine, zidovudine, nevirapine
25 Completed The Effect of Hyperbilirubinemia on CV Disease, Neurocog Function and Renal Function
Condition: HIV
Intervention:
26 Active, not recruiting School Support as Structural HIV Prevention for Adolescent Orphans in Kenya
Condition: HIV
Intervention: Behavioral: School Support Intervention
27 Recruiting Comorbidity and Aging With HIV
Conditions: HIV-1-infection;   Comorbidity;   Ageing
Intervention:
28 Completed Safety and Efficacy Study of BMS-790052 Plus Peg-Interferon Alfa 2a and Ribavirin in Untreated Hepatitis C Patients Coinfected With HIV Virus
Condition: Hepatitis C, Genotype 1
Interventions: Drug: BMS-790052 (Daclatasvir);   Drug: Ribavirin;   Drug: Peg-Interferon alfa 2a
29 Completed Obesity in HIV After Antiretroviral Therapy
Conditions: HIV;   AIDS;   Obesity
Intervention: Drug: antiretroviral therapy
30 Active, not recruiting Culturally Sensitive Intervention to Improve Retention in HIV Care for Latino MSM
Condition: HIV
Intervention: Behavioral: Peer Navigator Intervention
31 Recruiting Implementation of an Efficacious Intervention for High Risk Women in Mexico
Conditions: HIV;   Syphilis;   Gonorrhea;   Chlamydia
Interventions: Behavioral: Mujer Segura;   Behavioral: CENSIDA counseling program
32 Completed Trial To Assess The Lipid-Lowering Effect Of Adding Tenofovir/Emtricitabine Co-Formulation Vs Placebo To Hiv-1-Infected Subjects With Dyslipidemia And Sustained Viral Load Suppression Under Monotherapy With Ritonavir-Boosted Protease Inhibitors
Conditions: HIV;   Dyslipidemia
Interventions: Drug: Truvada® (300 mg tenofovir disoproxil fumarato/200 mg emtricitabine);   Drug: Placebo
33 Recruiting Korean Post-marketing Surveillance for Reyataz®
Condition: HIV-1
Intervention: Drug: No Intervention
34 Completed
Has Results
Rifaximin as a Modulator of Microbial Translocation and Immune Activation
Condition: HIV-1 Infection
Intervention: Drug: Rifaximin
35 Unknown  Prospective Study on HIV-related Hodgkin Lymphoma
Condition: HIV-associated Hodgkin Lymphoma
Interventions: Drug: Doxorubicin;   Drug: Bleomycin;   Drug: Vinblastine;   Drug: Dacarbazine;   Drug: Etoposide;   Drug: Cyclophosphamide;   Drug: Vincristine;   Drug: Procarbazine;   Drug: Prednisone
36 Completed Unboosted Atazanavir as Initial ART Therapy in China
Condition: Antiretroviral Therapy
Intervention:
37 Completed A Prospective Observational Study of the Clinical Performance of Femplant in Pakistan
Condition: Contraception
Intervention:
38 Completed GSK1349572 Exposure in Blood, Seminal Fluid, and Rectal Fluid and Tissue in Healthy Male Subjects
Condition: Healthy
Intervention: Drug: dolutegravir
39 Active, not recruiting Safety,Effectiveness and Acceptability of Sino-implant II in DR
Condition: Contraception
Interventions: Drug: Jadelle;   Drug: Sino-implant (II)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-39) Next Page   
Indicates status has not been verified in more than two years